CAN SYSTEMIC SKLERODERMIA BE A REASON FOR DEVELOPMENT OF THE STROKE? ANALYSIS OF CLINICAL OBSERVATION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Systemic scleroderma (SS) is one of the rarest forms of collagenosis, and as many researchers note, primary damage to the central nervous system is much less likely with this disease. In the literature, cases of development of stroke and transient ischemic attacks in patients with SS are usually represented by single observations. However, with the use of modern methods of neuroimaging, the frequency of detection of individuals who have had a stroke against the background of the SS may be significantly higher. Description of the clinical case. The clinical observation of 66-year-old SS patient with ischemic stroke developed against the background of the rapidly progressing course of SS is presented. This case reflects the complexity of diagnosis and treatment in the pre-stroke period with the combination of SS and peripheral vascular disease, as well as difficulties and interpretation of the causes of stroke in such patients. Conclusion. After discussing the presented observation at the pathoanatomical conference, the causal relationship between the SS and the developed multifocal cerebral infarction was confirmed, the pathogenetic variant of ischemic stroke was reviewed: the atherothrombotic subtype was replaced by the «other established etiology» according to the TOAST classification.

Full Text

Restricted Access

About the authors

V. V Gudkova

Pirogov Russian National Research Medical University

Email: gudkova.valentina@gmail.com
PhD in Medical Sciences, Associate Professor at the Department of Neurology

E. I Kimelfeld

Pirogov Russian National Research Medical University

Department of Neurology, Neurosurgery and Medical Genetics

A. G Gutsalyuk

Hospital for Veterans of Wars № 3, Moscow

S. Yu Petrova

Hospital for Veterans of Wars № 3, Moscow

L. V Stakhovskaya

Pirogov Russian National Research Medical University; Research Institute of Cerebrovascular Pathology and Stroke, Pirogova Russian National Research Medical University

Department of Neurology, Neurosurgery and Medical Genetics

References

  1. Das C.P., Prabhakar S., Lal V., Kharbanda P.S. Scleroderma, stroke, optic neuropathy: a rare association. Neurology India. 2002;50(4):504-7.
  2. Lu P., Xia P., Hu X. Recurrent Ischemic Stroke in Systemic Sclerosis - a Case Report. Cesk Slov Neurol N. 2009;72/105(6):566-69.Patel K., Khan M., Silver B. Ischemic Stroke in Patients with Scleroderma: Case Reports and Review of the Literature. Neurology. 2013;80(7). Supplement P06.220. http://www.neurology.org/ content/80/7_Supplement/P06.220 - aff-2
  3. Bougea A., Anagnostou E., Spandideas N., et al. An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review. Einstein. 2015;13(4):627-35. doi: 10.1590/S1679-45082015RW3308.
  4. Lucivero V., Mezzapesa D.M., Petruzzellis M., et al. Ischaemic stroke in progressive systemic sclerosis. Neurol Sci. 2004;25(4):223-33.
  5. Пизова Н.В. Церебральная сосудистая патология при системной склеродермии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2004;4:19-23.
  6. Chiang CH., Liu C.J., Huang C.C., et al. Systemic sclerosis and risk of ischaemic stroke: a nationwide cohort study. Rheumatology (Oxford). 2013;52(1):161-65. doi: 10.1093/rheumatology/kes352.
  7. Ungprasert P., Sanguankeo A., Upala S. Risk of ischemic stroke in patients with systemic sclerosis: A systematic review and meta-analysis. Mod Rheumatol. 2016;26(1):128-31. doi: 10.3109/14397595.2015.1056931.
  8. Cannarile F., Valentini V., Mirabelli G., et al. Cardiovascular disease in systemic sclerosis. Ann Transl Med. 2015;3(1):8. doi: 10.3978/j.issn.2304-5839.2014.12.12.
  9. Алекперов Р.Т. Системная склеродермия. Лечащий врач. 2004;7. https://www.lvrach.ru/2004/07/4531516/
  10. Шостак Н.А., Клименко А.А. Системная склеродермия: современная классификация и методы лечения. Лечебное дело. 2009;4:4-12.
  11. Конева О.А., Овсянникова О.Б., Старовойтова М.Н., и др. Определение чувствительности новых критериев системной склеродермии на российской популяции пациентов. Научно-практическая ревматология. 2015;53(4):361-66.
  12. Psarras A., Soulaidopoulos S., Garyfallos A., et al. A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int. 2017; 37(1):85-95. Doi:10.1007/ s00296-016-3530-3.
  13. Каминский Ю.В., Матвеева Н.Ю., Матвеев Ю.А. Склеродермическая энцефаломиелопатия. Тихоокеанский медицинский журнал. 2016; 2:108-12.
  14. Gordon R.M., Silverstein A. Neurologic manifestations in progressive systemic sclerosis. Arch Neurol. 1970;22:126-34.
  15. Bartynski W.S. Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features. Am J. Neuroradiol. 2008;29(6):1036-42. Doi: https://doi.org/10.3174/ajnr.A0928.
  16. Reidy M.E., Steen V., Nicholas J.J. Lower extremity amputation in scleroderma. Arch Phys Med Rehabil. 1992;73(9):811-13.
  17. Soriano A., Afeltra A., Shoenfeld Y. Is atherosclerosis accelerated in systemic sclerosis? Novel insights. Curr Opin Rheumatol. 2014;26(6):653-57. Doi:10.1097/ BOR.0000000000000115.
  18. Ананьева Л.П., Александрова Е.Н. Аутоантитела при системной склеродермии: спектр, клинические ассоциации и прогностическое значение. Научнопрактическая ревматология.2016;54(1):86-99.
  19. Системная склеродермия. URL: http://serdec.ru/ bolezni/sistemnaya-sklerodermiya

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies